CME: Critical Care Pharmacotherapy Literature Update - (August, 2011)

Program Description / Statement of Need:

In this online CME self-learning program:

This is a monthly review of select articles in the medical literature pertaining to pharmacotherapy used incritically ill patient populations. The content below is for information purposes only and is intended tohighlight recent articles that may be of interest to those caring for patients in various intensive care orrelated settings. Though some core content from the publications is presented, the reader is encouragedto review each article in full for additional detail in order to fully interpret the study, its findings, and itsapplicability to practice.

Target Audience:

This program has been designed for a multidisciplinary physician, nurse, and pharmacist audience including: ICU / Anesthesia / Peri-op / Intensivists / Trauma / Critical Care

Program Objectives:

By the end of the session the participant will be able to:

Be able to describe the study: Procalcitonin Guided Interventions Against Infections To Increase EarlyAppropriate Antibiotics And Improve Survival In The Intensive Care Unit: A Randomized Trial

Be able to describe the study: Clue: A Randomized Comparative Effectiveness Trial Of Iv Nicardipine Versus Labetalol Use In The Emergency Department

Be able to describe the study: Randomized Controlled Trial Comparing The Effect Of 8.4% Sodium Bicarbonate And 5% Sodium Chloride On Raised Intracranial Pressure After Traumatic Brain Injury

Be able to describe the study: Safety And Efficacy Of Heparin Or Enoxaparin Prophylaxis In Blunt Trauma Patients With A Head Abbreviated Injury Severity Score >2

Be able to describe the study: Dosing Frequency of Unfractionated Heparin Thromboprophylaxis: A Meta-analysis

Accreditation:

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through ScientiaCME. ScientiaCME is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation:ScientiaCME designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™ toward the AMA Physician's Recognition Award. Physicians should only claim credit commensurate with the extent of their participation in the activity.

As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review ScientiaCME.

-Take the Pre-Test (optional). Completion of the pre-test will help us evaluate the knowedge gained by participating in this CME activity.

-View the selected Critical Care Pharmacotherapy Literature Updates You may view this is in more than one session, and may pause or repeat any portion of the presentation if you need to. You are encouraged to read the articles in full for additional detail in order to fully interpret the study, its findings, and its applicability to practice, however this is not required.

-Take the post-test

-Complete the program evaluation and CME registration. A CE certificate will be emailed to you.

Perform Pre-Test (optional)
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.